News Center

Alira Health’s most recent news, press mentions, and media assets

Alira Health is a global healthcare consultancy redefining evidence generation through patient partnerships. By uniting strategic consulting, CRO services, and technology, the company supports life sciences organizations in accelerating development, improving access, and delivering measurable outcomes across the product lifecycle. Our approach helps clients improve access, adoption, and impact, guided by the voice of the patient.

If you’re a journalist interested in covering our latest news, events, reports, articles, webinars, case studies, scientific articles or interviewing our experts, please submit a media inquiry with the form below. Unlock the full potential of your articles by utilizing our resources, curated to provide accurate and insightful information.

Alira Health in the news

Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health

Published July 22, 2026 on GlobeNewswire

Alira Health, a global healthcare consultancy, today released the 2026 Biologics Contract Manufacturing Report, its annual analysis of the global contract development and manufacturing organization (CDMO) market. The report finds that the global biologics CDMO market grew to $23.2 billion in 2025, and competitive advantage is increasingly shifting from manufacturing scale to specialized capabilities supporting next-generation biologics. Go to the article

infuse Life Science Enters Strategic Partnership with Alira Health: Combining Japan-Rooted Medical Device and Diagnostics Expertise with Bio-Centric Global Life Sciences Strategy to Advance Healthcare to Its Next Stage

Published June 18, 2026 on infuse Life Science

infuse Life Science, Inc. today announced that it has entered into a regional partnership with Alira Health, a global healthcare advisory firm headquartered in Framingham, Massachusetts, USA. This partnership unites iLS’s technology, market-insight, and commercialization expertise in the medical device and in-vitro diagnostics (IVD) fields—built from a base in Japan—with the comprehensive life sciences strategy that Alira Health has delivered worldwide, centered on pharmaceuticals and biotech.
Go to the article

Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation

Published April 28, 2026 on GlobeNewswire

Alira Health today announced its partnership with Patient Focused Medicines Development (PFMD), a coalition dedicated to enabling patient engagement by providing the frameworks and collaborative networks needed to make patient-centered healthcare a worldwide reality. Go to the article

New US Patient Registry to Track MG Using Real-World Data

Published April 16, 2026 on Myasthenia Gravis News

A new U.S.-based patient registry is enrolling people with myasthenia gravis (MG) to help researchers better understand how the disease progresses, how treatments are used in the real world, and how MG affects patients’ daily lives. Launched by Alira Health in partnership with the Autoimmune Neurology Alliance, the AXIS Registry will collect patient-centered information for 10 years through surveys and digital health tools. The aim is to provide a broader view of life with MG than doctors can capture in routine office visits. Go to the article

Alira Health and Autoimmune Neurology Alliance (AiNA) Launch AXIS Registry, Advancing Real-World and Patient-Centered Research in Autoimmune Neurology

Published April 15, 2026 on GlobeNewswire

Alira Health, in partnership with the Autoimmune Neurology Alliance (AiNA), today announced the launch of the AXIS Registry, a new initiative designed to advance research and improve patient care in autoimmune neurological diseases, including myasthenia gravis (MG). Go to the article

Global Medtech CDMO Market Grows to $96.5B in 2025 as Pharma-Medtech Convergence Emerges as a Defining Accelerator

Published March 31, 2026 on GlobeNewswire

Alira Health, a global healthcare consulting and research organization, today released its sixth annual report on the state of the contract development and manufacturing organization (CDMO) market in medtech, analyzing trends and data from 2025. The findings show the global market reached $96.5 billion, reflecting 8.4% year-over-year growth. The market is projected to grow to $143.6 billion by 2030, at a compound annual growth rate (CAGR) of 8.3%. Go to the article

Alira Health Earns EcoVadis Silver Rating, Ranking in the Top 15 Percent Globally

Published February 12, 2026 on GlobeNewswire

Alira Health today announced it has been awarded a Silver rating by EcoVadis, a globally recognized provider of business sustainability ratings. This achievement reflects Alira Health’s continued commitment to operating responsibly in service of its core mission: improving the lives of patients worldwide. Go to the article

Alira Health Opens the Registration for the Third Edition of the Global Payer Forum

Published January 29, 2026 on GlobeNewswire

Alira Health today opens the registration for the third edition of its Global Payer Forum, an annual online event examining the key trends reshaping access to healthcare innovation across global health systems. Go to the article

Alira Health Announces Bill Achtmeyer and George G. Montgomery as Members of Board of Directors

Published January 14, 2026 on GlobeNewswire

Alira Health, a global healthcare consultancy partnering with life sciences companies and patients to deliver evidence-based solutions, announced that Bill Achtmeyer and George G. Montgomery, MBA are serving as members of its Board of Directors. Mr. Montgomery was also elected Chairman of the Board. Go to the article

Alira Health Appoints Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador

Published December 17, 2025 on GlobeNewswire

Alira Health, a global advisory firm and CRO, today announced the appointment of Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador. Dr. Schaffert is a highly respected biopharmaceutical leader whose career includes senior executive roles and multiple Board of Directors positions across the healthcare sector. Go to the article

Arizona Approves First-Of-Its-Kind Study Exploring Whole Mushroom Psilocybin Therapy To Treat PTSD

Published October 29, 2025 on Marijuana Moment

Arizona officials have approved and funded a first-in-the-nation clinical trial investigating the potential of whole mushroom psilocybin to treat post-traumatic stress disorder (PTSD) in first responders and military veterans—with authorization from the federal Food and Drug Administration (FDA). The state-funded study is being spearheaded by the Scottsdale Research Institute (SRI), with support from the research firm Alira Health. Go to the article

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

Published October 23, 2025 on GlobeNewswire

Alira Health released its 2025 Global Drug Delivery System Trends Report, highlighting the rapid evolution of the global drug delivery systems market. Go to the article

Alira Health Becomes First Platinum CRO Partner of the Wound Care Collaborative Community, Expanding Ongoing Work to Advance Wound Healing Innovation

Published September 24, 2025 on GlobeNewswire

Alira Health announced today that it has become the first Platinum CRO Partner of the Wound Care Collaborative Community (WCCC). Go to the article

The Global Biologics Outsourcing Market Accounted for $20.7B in 2024 Driven by Rising Demand for Modality-Specific, End-to-End CDMO Capabilities, Finds Alira Health

Published July 31, 2025 on GlobeNewswire

This Alira Health report offers analysis of the global rebound in biologics outsourcing following a year of macroeconomic headwinds and market contraction. Go to the article

Alira Health Launches Patient Engagement Certification for Life Sciences Organizations

Published June 17, 2025 on GlobeNewswire

Alira Health launches its Patient Engagement Certification to train life sciences teams in ethical, credible, and compliant patient engagement practices. Go to the article

Global Medtech Outsourcing Market Grows to $89B in 2024 as CDMOs Emerge as Strategic Partners, Finds Alira Health

Published May 15, 2025 on GlobeNewswire

Alira Health today released its fifth annual report on the state of the contract development and manufacturing organization (CDMO) market in medtech. Go to the article

America’s Best Management Consulting Firms

Published March 18, 2025 on Forbes.com

With an estimated 955,000 consulting firms in the U.S., company executives seeking strategic help may be overwhelmed by the options. To the rescue comes Forbes’ tenth-anniversary list of America’s Best Management Consulting Firms. Go to the article

Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention

Published February 27, 2025 on GlobeNewswire

Alira Health is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering initiative in the field of cancer prevention led by Gustave Roussy, one of the world’s top cancer research institutes. Go to the article

Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence

Published January 14, 2025 on GlobeNewswire

Alira Health launches its innovative technology platform SpherePX, designed to drive RWE collection and elevate patient engagement and retention. Go to the article

Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation

Published December 17, 2024 on GlobeNewswire

Alira Health announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor. Go to the article

Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market

Published December 3, 2024 on GlobeNewswire

Gain comprehensive insights into the ADC market with the Alira Health 2024 Global Antibody-Drug Conjugates Report’s in-depth analysis. Go to the article

Alira Health Releases Global Report on Trends and Competitive Dynamics in the Biosimilar Market

Published October 29, 2024 on GlobeNewswire

The report provides a comprehensive analysis of global biosimilar trends, with a focus on competitive dynamics in the US and Europe. It highlights key players, their biosimilar-related licensing and M&A activities, and examines the legal and regulatory landscape influencing market growth. Go to the article

Navigating the Commercial Cycle of Biologics Manufacturing

Published July 31, 2024 on BioProcess International

The journey for biotechnology companies and contract development and manufacturing organizations (CDMOs) from research and development (R&D) to market commercialization is marked by both opportunities and challenges. Go to the article

Alira Health Tapped to Assist in Arizona Psilocybin Studies

Published June 18, 2024 on Green Market Report

Psychedelic clinical research firm Alira Health will collaborate with the Scottsdale Research Institute (SRI) to provide regulatory and clinical support to bring clinical research of psilocybin to the state of Arizona. Alira Health said that the partnership would provide strategic guidance and support in regulatory strategy, regulatory submissions, regulatory monitoring, clinical trial design, and clinical operations. Go to the article

RedCrow and Republic Forge Strategic Partnership to Transform Healthcare Crowdfunding

Published June 6, 2024 on GlobeNewswire

RedCrow, an Alira Health company and specialized equity crowdfunding platform dedicated to vetted healthcare investment opportunities, and Republic, a leading equity crowdfunding platform with an investor network of over 3 million users, proudly announced today their strategic partnership to reshape the landscape of healthcare crowdfunding. Go to the article

MATCH Biosystems, MIKROBIOMIK, and Oniria Therapeutics have been selected for the second edition of the Mentoring Program in Market Access for SMEs by AseBio and Alira Health

Published April 24, 2024 on asebio.com

Last January, AseBio and Alira Health, a global advisory and clinical research firm, launched the second edition of their Mentoring Program in Market Access for SMEs. An initiative that, following the success achieved with its first edition, aims to continue supporting and driving market access for innovation from small Spanish biotechnology companies. Go to the article

Check out the 3 companies chosen to take part in ‘Startup Support Program 2024’

Published April 24, 2024 on biocat.cat

Biocat and the international consultancy firm Alira Health are promoting the second annual Startup Support Program 2024, focused on helping advanced and emerging therapies companies in the BioRegion of Catalonia reach the market. Go to the article

Lipogems Announces Last Patient Enrolled In The U.S. FDA IDE Arise Study For The Treatment Of Knee Osteoarthritis

Published April 10, 2024 on PR Newswire

Lipogems, a clinical stage- global medical technology company, announces it has completed enrollment in the ARISE I U.S. FDA IDE study, which aims to examine MicroFat versus corticosteriod injection for the treatment of Knee Osteoarthritis (OA). Efficacy and safety results from ARISE 1 are expected to be announced in 2025. Go to the article

Alira Health Joins Forces with APMA to Advance Podiatric Registry

Published March 27, 2024 on Innovation & Entrepreneurs News

Alira Health, a global advisory and clinical research firm, joined the American Podiatric Medical Association (APMA), the largest professional association representing podiatrists, physicians and surgeons who treat the foot and ankle, as a corporate member to help advance APMA’s Podiatric Registry. Go to the article

America’s Best Management Consulting Firms

Published March 12, 2024 on Forbes.com

There are more than one million management consulting firms in the United States, all collectively expected to generate almost $370 billion in revenue this year, according to IBISWorld. Across dozens of industries, consultants throughout the country help companies navigate challenges and seize opportunities in IT strategy, risk management, digital transformation and more. Go to the article

Best Consulting Firms in EMEA in Each Practice Area

Published March 2024 on Vault

Vault, the leader in data-driven employer rankings and verified employee reviews, released its 2024 rankings of the Best Consulting Firms to Work For in the Europe, Middle East, and Africa (EMEA) and Asia-Pacific (APAC) regions. Alira Health was recognized as number 9 of the 2024 Best Consulting Firms in EMEA for Health Sciences Consulting. Go to the article

Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report

Published February 26, 2024 on Markets Insider

This report offers a comprehensive analysis of trends in the global medtech contract manufacturing (CDMO) market and includes a deep dive into the contract manufacturing landscape in France, Germany, Italy, Ireland, Switzerland, the UK, and the Nordic countries. Go to the article

Robotic-Assisted Surgery: Pioneering a New Era in Orthopedic Procedures

Published February 3, 2024 on BNN Breaking

Alira Health, in collaboration with MassMEDIC, publishes a comprehensive review on Robotic-Assisted Surgery in Orthopedic Procedures, predicting a 10% annual growth over the next five years. Go to the article

Alira, Sancare partner to enhance healthcare data analysis in France

Published January 12, 2024 on Hospital Management

Global advisory and clinical research company Alira Health has announced a partnership with Sancare, a French artificial intelligence (AI)-driven healthtech company. Go to the article

Top 5 Most Listened-to Podcasts of 2023

Published December 26, 2023 on Applied Clinical Trials

Gabriele Brambilla, CEO of Alira Health, discusses how data sharing in clinical research should be implemented to value the person. He also highlights his career path and how he became so interested in healthcare innovation. Go to the article

How pharma is unleashing the benefits of real-world evidence along the value chain

Published December 14, 2023 on reutersevents.com

By collecting and analysing real-world data (RWD), pharmaceutical companies are generating key evidence that supports regulatory authorisations and influences decisions at health technology assessment bodies and payers. Go to the article

AseBio y Alira Health concluyen el programa de Mentoring en Market Access para pymes con excelentes resultados

Published December 4, 2023 on interempresas.net

AseBio y Alira Health, consultoría especializada global cuya misión es humanizar la asistencia sanitaria en colaboración con los pacientes a través de una amplia gama de servicios a lo largo del ciclo de vida del producto, han finalizado el programa de Mentoring en Market Access para pymes socias de AseBio con excelentes resultados. Go to the article

How to Enable Patient-Centric Co-Design for Better Healthcare Solutions

Published November 30, 2023 on Xtalks Online

Patient-centric co-design refers to an approach where patients or end-users are actively involved with healthcare professionals, designers and other stakeholders to develop healthcare services or products. Go to the article

Biotech Trends and Industry Insights for 2024 and Beyond

Published November 15, 2023 on Xtalks Online

In the dynamic and ever-evolving landscape of biotechnology, industry leaders must stay informed of biotech trends and garner industry insights for 2024 and beyond. Go to the article

Alira Health joins partnership for Lupus research

Published November 7, 2023 on Worcester Business Journal

Framingham-based Alira Health has partnered with FORWARD, a national database for rheumatic diseases, to create an enhanced patient registry for autoimmune disease Lupus. Go to the article

Alira Health and FORWARD Launch Enhanced Lupus Patient Registry, Accelerating Solutions for Patients

Published November 6, 2023 on Associated Press

Patients with Lupus share their health experiences within a secure registry to advance research, support better clinical decision-making, and improve patient outcomes. Go to the article

3 Best Practices for Patient Engagement in Clinical Trials

Published November 1, 2023 on Xtalks Online

The revolution in clinical research is here, and it’s embodied by a single, powerful word: “patients.” The inclusion of patients during clinical development is not only a moral imperative but a strategic necessity in modern medical research. Go to the article

Trends and Challenges in Diabetes Management Devices

Published October 13, 2023 on PM360 Online

During the last 100 years since the discovery of insulin, a hormone that helps the body regulate blood glucose levels, the repertoire of tools available to the healthcare community for diabetes has exploded. Today, patients have multiple ways to manage their glucose levels with a wide range of diabetes management devices. Alira Health’s report “Diabetes Management Devices: Market Trends 2023”¹ analyzes the market landscape, examines the trends, and highlights some of the common challenges faced by players. Go to the article

Innovating Healthcare with Gabriele Brambilla, CEO Alira Health | Season 2 Episode 11

Published September 20, 2023 on Med-Tech World Podcast

In this episode of The MedTech World Podcast, we interviewed Gabriele Brambilla, CEO of Alira Health. During the interview, we will delve into topics such as:, Gabriele’s experiences and journey in the Healthcare industry, his current work heading Alira Health, a global healthcare firm whose mission is to humanize healthcare and life sciences with the patients, Gabriele’s vision and role in shaping the future of Med-Tech and Digital Health. Go to the article

Manufacturing Challenges of Therapeutic Antibody-Drug Conjugates

Published September 19, 2023 on BioProcess International

The pharmaceutical industry has come a long way since 1907, when Paul Ehrlich coined the term “magic bullet” for treatments that could target disease-causing cells while spacing normal, healthy cells. Go to the article

New Biologics and Advanced Therapies:
Opportunities & Challenges in the Therapeutic & CDMO Markets

Published September 13, 2023 on CHEManager International

The pharmaceutical market is undergoing a profound transformation, driven by innovation among biologics and advanced therapies (ATs). This shift is not only redefining the treatment landscape but also presenting new opportunities and challenges related to the drug development and manufacturing value chain. Go to the article

Collaborating to compete: objectives and perspectives of Federated Innovation @MIND

Published September 12, 2023 on La Reppublica

A “federation” of companies and research bodies has the aim of transforming Italy – in particular Lombardy and Milan – into a new Silicon Valley. To date, 41 large companies have already been involved in the project. Go to the article

BIOSPAIN2023 Interview – Patients with a rare disease face a large number of unmet needs.

Published September 4, 2023 on AseBio

We talked about the role of patients in developing solutions for rare diseases with Annabel de María, Chief Patient Officer of Alira Health, Gold Sponsor of BIOSPAIN 2023. Go to the article

The World’s Best Management Consulting Firms

Published August 16, 2023 on Forbes.com

Offering a range of services—improving sustainability practices, advancing marketing strategy, or simplifying supply chain—consultants help companies solve their biggest problems. To help executives assess the options, Forbes partnered with the research company Statista to create our second annual World’s Best Management Consulting Firms list. Go to the article

America’s Best Management Consulting Firms

Published March 15, 2023 on Forbes.com

The number of management consulting firms in the U.S. has grown 2.6% per year over the last five years, according to IBISWorld. And they’ve been busy: consulting firms are tasked with guiding companies as they contend with upheaval in a wide range of areas—from economic instability and technological advances to shifting workplace norms and an increased focus on sustainability. Go to the article

Executive Roundtable: The Rise of RWD in Clinical Research

Published May 17, 2023 on Applied Clinical Trials

Senior leaders gather to share insights on the increased investment in real-world data to boost the quality and efficiency of drug development—as the industry begins to more widely embrace evidence of proven outcomes in aiding approaches in clinical trial design, patient engagement, regulatory decision-making, and other areas. Go to the article

Pharma 2023: Unleash RWE Benefits Along the Value Chain

Published Apr. 20, 2023 on PharmExec.com

Moderator Catia Proenca, director in real-world solutions, Alira Health; Rolland Kacsoh, global product director, iron disorders and rare anemias, rare blood, early assets, Novo Nordisk; […] Go to the article

EAE Business School Barcelona lanza el nuevo Global Máster en Sostenibilidad y RSC

Published Apr. 17, 2023 on Corresponsables

En un entorno en el que cada vez se requieren de más perfiles capaces de liderar la estrategia sostenible de las empresas, EAE Business School ha lanzado el Global Máster en Sostenibilidad y RSC en su campus de Barcelona. Go to the article

Massachusetts Life Sciences Week Focuses Spotlight on Commonwealth’s Global Leadership

Published Apr. 11, 2023 on Associated Press

April 24-28 to be celebrated as Life Sciences Week in Massachusetts; Three marquee convenings set stage to showcase the Massachusetts ecosystem’s global impact. Go to the article

Data In Clinical Trials—How Did We Get Here And What’s Next?

Published Apr. 4, 2023 on Applied Clinical Trials

Startup AI, le 25 imprese italiane più interessanti

Published Apr. 3, 2023 on StartUp News

Ecco 25 imprese italiane specializzate nell’uso dei sistemi basati su Intelligenza Artificiale per semplificare la vita di lavoratori e aziende o migliorare la società. La nostra redazione ha selezionato le più interessanti sul mercato Go to the article

Rare Community Profiles: Alira Health and the MGFA Partner to Develop a Myasthenia Gravis Registry

Published Mar. 22, 2023 on Patient Worthy

An estimated ~0.002% of people living within the United States have myasthenia gravis, a rare autoimmune neuromuscular disease. Similar to many other rare conditions, myasthenia gravis tends to be misunderstood and under-researched; more funding and research are needed to better understand the disease itself, its long-term impacts, and potential treatment options. Go to the article

Gabriele Brambilla CEO Alira Health

Published Feb. 15, 2023 on Investment Reports

Although Alira Health was officially founded in 1999, the business model you see today was only defined in 2015, when I acquired the company through a leveraged buyout with a French partner. Go to the article

Changing Faces: Agency and investor hires in Dec and Jan

Published Feb. 15, 2023 on Pharma Phorum

Though decidedly slower than some of the other sectors we tracked, December and January did have their share of hires in the marketing and communications world around pharma, as well as one notable investor hire. Go to the article

Report: Contract medtech manufacturing poised for growth in 2023

Published Feb. 14, 2023 on Manufacturing Dive

The U.S. medtech contract development and manufacturing organization (CDMO) market will grow 12.9% this year, according to a report by healthcare advisory and clinical research firm Alira Health and the Massachusetts Medical Device Industry Council (MassMEDIC). Go to the article

Digital program gets school kids moving

Published Feb. 8, 2023 on The University of Sydney

Sydney school kids participating in an innovative program developed by researchers at the University of Sydney increased their daily step count by 30 percent, while learning how to set goals and understand different levels of physical activity. Go to the article

The Playbook for Patient Engagement in MedTech in the U.S. is Launched

Published Jan. 31, 2023 on Yahoo Finance

A Framework for Executing Successful and Sustainable Patient Engagement Strategies Across the Lifecycle Management of Medical Diagnostics and Devices. Go to the article

MGFA Relaunches Patient Registry to Help in Clinical Research

Published Jan. 31, 2023 on Myasthenia Gravis News

The Myasthenia Gravis Foundation of America (MGFA) has partnered with Alira Health to relaunch a patient registry for people with myasthenia gravis (MG) that “capitalizes on technological advances,” the nonprofit announced. Go to the article

Media assets

WHO WE ARE

DOWNLOAD OUR MEDIA KIT

READ OUR BLOG

Media Inquiry

If you are a journalist and want to know more about Alira Health, fill in the below form and we will get back to you as soon as we can.

News Center

Alira Health’s most recent news, press mentions, and media assets

Alira Health in the news

Recognitions

Media assets

Media Inquiry